Asian stocks struggled to extend the week’s rally on Wednesday and gold and bonds firmed as a sceptical press report dented some hopes for a COVID-19 vaccine and concerns about bumps in the global recovery from the pandemic returned.
Venezuela’s central bank has made a legal claim to try to force the Bank of England to hand over €930 million ($1.02 billion) of gold so President Nicolas Maduro’s government can fund its coronavirus response, according to the document submitted in a London court. The claim follows a request Venezuela made to the Bank of England in April to sell part of its gold reserves there and send the proceeds to the United Nations to help with the country’s coronavirus-fighting efforts. The Bank of England declined to comment on the claim. …read more […]
Democratic lawmakers on Tuesday urged the Trump administration to answer “serious questions” about Taiwan Semiconductor Manufacturing Co Ltd’s plans to build a U.S.-based $12 billion plant, flagging national security concerns and potentially undisclosed subsidies.
Moderna, Inc. (NASDAQ:MRNA) stock popped after positive news about the company’s coronavirus vaccine candidate. After the shares climbed 20% to record highs, the company announced plans to sell $1.25 billion in new shares to fund manufacturing and distribution of its vaccine candidate. Update on Moderna’s coronavirus vaccine Moderna’s coronavirus vaccine is officially referred to as […] …read more […]
Shares of Fujifilm Holdings Corp fell on Wednesday after Kyodo news agency reported that so far there has been no clear evidence of efficacy for its drug Avigan in treating the novel coronavirus in some clinical trials.
In such a confused financial environment, investors are hard-pressed to find a market strategy that will bring positive results. The old saws may not be reliable. One way out of the quandary is to follow the insiders. Corporate officers, entrusted by, and accountable to, shareholders, typically have deeper knowledge of their companies and business niches than is available to the average investor – and they can use that knowledge in their own trading. To avoid impropriety, insiders are required to make their trading public – a regulation that lets ordinary investors benefit from insider knowledge. So, when they buy or …read more […]
Shares of Fujifilm Holdings Corp tumbled more than 4% in early trade on Wednesday after a report its anti-flu drug Avigan was not showing apparent efficacy in coronavirus treatment in clinical trials so far.
Oil prices dipped on Wednesday as concerns over the lasting economic fallout from the coronavirus pandemic outweighed signs of improving demand and production cuts by major oil producers.
Asia stocks are likely to come under pressure on Wednesday, tracking declines on Wall Street while gold prices were buoyed by safe-haven demand as economic indicators pointed to more signs of recession.
Indigo Partners is teaming up with Oaktree Capital Management in its offer for Virgin Australia Holdings Ltd and will consider adding an Australian partner as the bidding process progresses, Indigo managing partner Bill Franke said.
Johnson & Johnson on Tuesday announced that it would stop selling its talc-based Johnson’s Baby Powder in the United States and Canada, making the decision after a consumer products “portfolio reassessment related to COVID-19.”
Apparel retailer Urban Outfitters Inc on Tuesday projected a 60% decline in same-store sales in the second quarter due to tepid demand recovery from the COVID-19 pandemic disruptions, sending its shares down 6% in extended trading.
The healthcare giant faces thousands of lawsuits from consumers claiming talc caused their cancer. …read more […]
The last time I profiled a company that I felt Wall Street got wrong, some War Room members used that information to immediately make profits of 65%!
“Just sold SHAK for 65%. Thanks Bryan.” – Marcel M., May 13 at 11:49 a.m.
So today, I’m doing it again…
One leading expert just said, “I have no idea how it’s going to survive.”
And yet, this stock currently trades with a forward price-to-earnings ratio of 128.
Everything is revealed for you below… Check it out now!
For full instructions on how to play picks like this, join me in The War Room!
The post Here’s Another Stock Wall …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
